Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes

Journal of Neuroscience

Volumn 26, Issue 31, 2006, Pages 8206-8216

  Ip, Chi Wang ^a   Kroner, Antje ^a   Bendszus, Martin ^a   Leder, Christoph ^a   Kobsar, Igor ^a   Fischer, Stefan ^a   Wiendl, Heinz ^a   Nave, Klaus Armin ^b   Martini, Rudolf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

Animal model; Inflammation; Leukodystrophy; Macrophages; Microglia; Multiple sclerosis; T lymphocytes

Indexed keywords

CD11B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEOLIPID PROTEIN; RAG1 PROTEIN; NERVE PROTEIN; PLP PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS BREEDING; DEMYELINATION; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; IMMUNOCOMPETENT CELL; MACROPHAGE; MALE; MOUSE; NEUROPATHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL CULTURE; DEMYELINATING DISEASE; IMMUNOLOGY; LYMPHOCYTE; PATHOLOGY;

ANIMALS; CELLS, CULTURED; DEMYELINATING AUTOIMMUNE DISEASES, CNS; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MYELIN PROTEOLIPID PROTEIN; NERVE TISSUE PROTEINS; OLIGODENDROGLIA;

EID: 33748138567     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1921-06.2006     Document Type: Article

References (73)

1. Anderson TJ, Schneider A, Barrie BA, Klugmann M, McCulloch MC, Kirkham D, Kyriakides E, Nave K-A, Griffiths IR (1998) Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J Comp Neurol 394:506-519.
2. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458-468.
3. Berger J, Moser HW, Forss-Petter S (2001) Leukodystrophies: recent developments in genetics, molecular biology, pathogenesis and treatment. Curr Opin Neurol 14:305-312.
4. Bieber AJ, Kerr S, Rodriguez M (2003) Efficient central nervous system remyelination requires T cells. Ann Neurol 53:680-684.
5. Bjartmar C, Yin X, Trapp BD (1999) Axonal pathology in myelin disorders. J Neurocytol 28:383-395.
6. Brookes RH, Pathan AA, McShane H, Hensmann M, Price DA, Hill AV (2003) CD8+ T cell-mediated suppression of intracellular Mycobacterium tuberculosis growth in activated human macrophages. Eur J Immunol 33:3293-3302.
7. Bruck W, Stadelmann C (2003) Inflammation and degeneration in multiple sclerosis. Neurol Sci 24 [Suppl 5]:S265-S267.
8. Byram SC, Carson MJ, DeBoy CA, Serpe CJ, Sanders VM, Jones KJ (2004) CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J Neurosci 24:4333-4339.
9. Carenini S, Maürer M, Werner A, Blazyca H, Toyka KV, Schmid CD, Ravich G, Martini R (2001) The role of macrophages in demyleinating peripheral nervous system of mice heterozygously deficient in PO. J Cell Biol 152:301-308.
10. Crocker PR (2005) Siglecs in innate immunity. Curr Opin Pharmacol 5:1-7.
11. de Waegh S, Brady ST (1990) Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: the trembler as an in vivo model for Schwann cell-axon interactions. J Neurosci 10:1855-1865.
12. de Waegh SM, Brady ST (1991) Local control of axonal properties by Schwann cells: neurofilaments and axonal transport in homologous and heterologous nerve grafts. J Neurosci Res 30:201-212.
13. de Waegh SM, Lee VMY, Brady ST (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451-463.
14. Edgar JM, Garbern J (2004) The myelinated axon is dependent on the myelinating cell for support and maintenance: molecules involved. J Neurosci Res 76:593-598.
15. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, Barrie JA, McCulloch MC, Duncan ID, Garbern J, Nave KA, Griffiths IR (2004) Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166:121-131.
16. Fung-Leung WP, Schilham MW, Rahemtulla A, Kundig TM, Vollenweider M, Potter J, van Ewijk W, Mak TW (1991) CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65:443-449.
17. Giess R, Mäurer M, Linker RA, Gold R, Warmuth-Metz M, Toyka KV, Sendtner M, Rieckmann P (2002) Association of a null mutation in the CNTF gene with early onset of multiple sclerosis. Arch Neurol 59:407-409.
18. Gould RM, Brady ST (2004) Neuropathology: many paths lead to hereditary spastic paraplegia. Curr Biol 14:R903-R904.
19. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
20. Gurlo T, von Grafenstein H (2003) Antigen-independent cross-talk between macrophages and CD8+ T cells facilitates their cooperation during target destruction. Int Immunol 15:1063-1071.
21. Hauben E, Butovsky O, Nevo U, Yoles E, Moalem G, Agranov E, Mor F, Leibowitz-Amit R, Pevsner E, Akselrod S, Neeman M, Cohen IR, Schwartz M (2000) Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci 20:6421-6430.
22. Hayreh SS (2001) The blood supply of the optic nerve head and the evaluation of it-myth and reality. Prog Retin Eye Res 20:563-593.
23. Hemmer B, Archelos JJ, Hartung HP (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3:291-301.
24. Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD (2005) Macrophages and neurodegeneration. Brain Res Brain Res Rev 48:185-195.
25. Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H (2000) The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol 107:161-166.
26. Hu P, McLachlan EM (2002) Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience 112:23-38.
27. Hu P, McLachlan EM (2003) Distinct functional types of macrophage in dorsal root ganglia and spinal nerves proximal to sciatic and spinal nerve transections in the rat. Exp Neurol 184:590-605.
28. Ibrahim SM, Gold R (2005) Genomics, proteomics, metabolomics: what is in a word for multiple sclerosis? Curr Opin Neurol 18:231-235.
29. Ip CW, Kroner A, Fischer S, Berghoff M, Kobsar I, Mäurer M, Martini R (2006) Role of immune cells in animal models for inherited peripheral neuropathies. Neuromol Med, 8:175-190.
30. Jones KJ, Serpe CJ, Byram SC, Deboy CA, Sanders VM (2005) Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury. Brain Behav Immun 19:12-19.
31. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189:865-870.
32. Kerschensteiner M, Stadelmann C, Dechant G, Wekerle H, Hohlfeld R (2003) Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann Neurol 53:292-304.
33. Kirkpatrick LL, Brady ST (1994) Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells. J Neurosci 1412:7440-7450.
34. Kobsar I, Berghoff M, Samsam M, Wessig C, Maurer M, Toyka KV, Martini R (2003) Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1. Brain 126:804-813.
35. Kobsar I, Oetke C, Kroner A, Wessig C, Crocker P, Martini R (2006) Attenuated demyelination in the absence of the macrophage-restricted adhesion molecule sialoadhesin (Siglec-1) in mice heterozygously deficient in P0. Mol Cell Neurosci 31:685-691.
36. Kotter MR, Zhao C, van Rooijen N, Franklin RJ (2005) Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 18:166-175.
37. Kovacs GG, Hoftberger R, Majtenyi K, Horvath R, Barsi P, Komoly S, Lassmann H, Budka H, Jakab G (2005) Neuropathology of white matter disease in Leber's hereditary optic neuropathy. Brain 128:35-41.
38. Kroner A, Mehling M, Hemmer B, Rieckmann P, Toyka KV, Maurer M, Wiendl H (2005) A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann Neurol 58:50-57.
39. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
40. Lassmann H (2004) Cellular damage and repair in multiple sclerosis. In: Myelin biology and disorders (Lazzarini RA, Griffin JW, Lassmann H, Nave KA, Miller RH, Trapp BD, eds), pp 733-762. Amsterdam: Elsevier Academic.
41. Lassmann H (2005) Multiple sclerosis pathology: evolution of pathogenetic concepts. Brain Pathol 15:217-222.
42. Linker RA, Mäurer M, Gaupp S, Martini R, Holtmann B, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M, Gold R (2002) CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 8:620-624.
43. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-714.
44. Magnus T, Schreiner B, Korn T, Jack C, Hong G, Antel J, Ifergan I, Chen L, Bischof F, Bar-Or A, Wiendl H (2005) Microglial expression of the B7-family member B7-H1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci 25:2537-2546.
45. Martini R (2001) The effect of myelinating Schwann cells on axons. Muscle Nerve 24:456-466.
46. Martini R, Toyka KV (2004) Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients. Lancet Neurol 3:457-465.
47. Matsushima GK, Taniike M, Glimcher LH, Grusby MJ, Frelinger JA, Suzuki K, Ting JPY (1994) Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell 78:645-656.
48. Mäurer M, Schmid CD, Bootz F, Zielasek J, Toyka KV, Oehen S, Martini R (2001) Bone marrow transfer from wild type mice reverts the beneficial effect of genetically-mediated immune deficiency in myelin mutants. Mol Cell Neurosci 17:1094-1101.
49. Medana I, Martinic MA, Wekerle H, Neumann H (2001) Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am J Pathol 159:809-815.
50. Mitrasinovic OM, Grattan A, Robinson CC, Lapustea NB, Poon C, Ryan H, Phong C, Murphy Jr GM (2005) Microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial- hippocampal organotypic coculture system. J Neurosci 25:4442-4451.
51. Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR, Schwartz M (2000) Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 15:331-345.
52. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869-877.
53. Moran LB, Graeber MB (2004) The facial nerve axotomy model. Brain Res Brain Res Rev 44:154-178.
54. Moser HW (2004) Adrenoleukodystrophies. In: Myelin biology and disorders (Lazzarini RA, Griffin JW, Lassmann H, Nave KA, Miller RH, Trapp BD, eds), pp 807-839. Amsterdam: Elsevier Academic.
55. Mueller M, Wacker K, Ringelstein EB, Hickey WF, Imai Y, Kiefer R (2001) Rapid response of identified resident endoneurial macrophages to nerve injury. Am J Pathol 159:2187-2197.
56. Neumann H (2003) Molecular mechanisms of axonal damage in inflammatory central nervous system diseases. Curr Opin Neurol 16:267-273.
57. Neumann H, Medana IM, Bauer J, Lassmann H (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci 25:313-319.
58. Oetke C, Vinson MC, Jones C, Crocker PR (2006) Sialoadhesin-deficient mice exhibit subtle changes in B- and T-cell populations and reduced immunoglobulin M levels. Mol Cell Biol 26:1549-1557.
59. Rahemtulla A, Fung-Leung WP, Schilham MW, Kundig TM, Sambhara SR, Narendran A, Arabian A, Wakeham A, Paige CJ, Zinkernagel RM, Miller RG, Mak TW (1991) Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4. Nature 353:180-184.
60. Raivich G, Jones LL, Kloss CUA, Werner A, Neumann H, Kreutzberg GW (1998) Immune surveillance in the injured nervous system: T-lymphocytes invade the axotomized mouse facial motor nucleus and aggregate around sites of neuronal degeneration. J Neurosci 18:5804-5816.
61. Readhead C, Schneider A, Griffiths I, Nave K-A (1994) Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12:583-595.
62. Redford EJ, Kapoor R, Smith KJ (1997) Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120:2149-2157.
63. Samsam M, Mi W, Wessig C, Zielasek J, Toyka KV, Coleman MP, Martini R (2003) The wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J Neurosci 23:2833-2839.
64. Schmid CD, Stienekemeier M, Oehen S, Bootz F, Zielasek J, Gold R, Toyka KV, Schachner M, Martini R (2000) Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J Neurosci 20:729-735.
65. Schwartz M (2001) Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines. Prog Neurobiol 65:489-496.
66. Serpe CJ, Kohm AP, Huppenbauer CB, Sanders VM, Jones KJ (1999) Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice. J Neurosci 19:RC7.
67. Serpe CJ, Coers S, Sanders VM, Jones KJ (2003) CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection. Brain Behav Immun 17:393-402.
68. Simons M, Kramer EM, Macchi P, Rathke-Hartlieb S, Trotter J, Nave KA, Schulz JB (2002) Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol 157:327-336.
69. Smith KJ, Kapoor R, Hall SM, Davies M (2001) Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 49:470-476.
70. Warshawsky I, Rudick RA, Staugaitis SM, Natowicz MR (2005) Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation. Ann Neurol 58:470-473.
71. Wolburg H, Bäuerle C (1993) Astrocytes in the lamina cribrosa of the rat optic nerve: are their morphological peculiarities involved in an altered blood-brain barrier? J Hirnforsch 343:445-459.
72. Wrabetz L, Feltri ML, Quattrini A, Imperiale D, Previtali S, D'Antonio M, Martini R, Yin X, Trapp BD, Zhou L, Chiu SY, Messing A (2000) P0 glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. J Cell Biol 148:1021-1033.
73. Yin X, Kidd GJ, Wrabetz L, Feltri ML, Messing A, Trapp BD (2000) Schwann cell myelination requires timely and precise targeting of P0 protein. J Cell Biol 148:1009-1020.